It's been a big year for biotech. And that momentum shows little sign of abating. Competition for top-seeded executives and board members has been fierce, with compensation at this level reflecting the sector's hunger for talent.
The "Board and Executive Compensation in the Biotechnology Industry" report’s intelligence gets more interesting where diversity and gender parity in the sector is concerned – and some fascinating observations can be inferred from that information. What can we do better? Where do we start?